JournalsHub
.online
Find My Journal
EC

Edward M. Chan

BC Cancer Agency CA

ORCID iD 0000-0002-1332-2987
91
Publications
2,821
Citations
22
H-Index
31
i10-Index
1.0
2yr Mean Cite
True
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Abstract 4483: The KAT6/7 inhibitor IDE574 disrupts tumor lineage identity and drug tolerance to deliver robust antitumor activity in biomarker selected indications.

Manav Gupta, Scott R. Tyler, N. Ghaddar, Carl Schultz, Pranav Gupta - Cancer Research, 2026
Cited by 0 Semantic Scholar

A Population Pharmacokinetic and Pharmacodynamic Analysis of Abemaciclib in a Phase I Clinical Trial in Cancer Patients OA

S. Tate, A. Sykes, P. Kulanthaivel, Edward Michael Chan, P. Turner - Clinical Pharmacokinetics, 2017
Cited by 54 Semantic Scholar

Phase 1 study of abemaciclib, an inhibitor of CDK 4 and 6, as a single agent for Japanese patients with advanced cancer

Y. Fujiwara, K. Tamura, S. Kondo, Y. Tanabe, S. Iwasa - Cancer Chemotherapy and Pharmacology, 2016
Cited by 55 Semantic Scholar

Research Topics

Advanced Breast Cancer Therapies (46) Melanoma and MAPK Pathways (25) Cancer-related Molecular Pathways (15) Synthesis and biological activity (11) Colorectal Cancer Treatments and Studies (11)

Affiliations

Scripps Research Institute
US 2005 - 2005
BC Cancer Agency
CA 2024 - 2024
National Institutes of Health
US 2005 - 2005
City Of Hope National Medical Center
US 2005 - 2005
California State University, Monterey Bay
US 2005 - 2005

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now